Finally, since we have shown that RCC tumors with high ADAM12 and CYP1B1 expression are characterized by enhanced proliferation and migration of cancer cells, it is reasonable to speculate that monitoring the invasiveness and the potential metastatic evolution of patients with the highest expression of these two genes will be an unmet goal of the follow‐up in the future. Here, ADAM12 is linked to cancer.